EWING, N.J., Aug. 25, 2016 /PRNewswire/ -- Essential Pharmaceuticals, LLC Chief Science Officer, Dr. Adam Elhofy, has published new data on Cell-Ess® universal titer boost and enhancer in the Computational and Structural Biotechnology Journal. The article is titled "Novel Cell-Ess® supplement used as a feed or as an initial boost to CHO serum-free media results in a significant increase in protein yield and production." Computational and Structural Biotechnology Journal is an online peer-reviewed journal, and the study can be viewed in its entirety on the journal's website.
Cell-Ess is the world's first universal titer boost and enhancer that works across a wide range of media systems. It can be used as a building block to create robust media to address the cell culture demands of bioproduction. Cell-Ess is a chemically-defined and animal component free supplement that delivers critical components, including essential fats, needed for membrane synthesis. Its patent-pending lipid delivery technology limits oxidation, degradation, and adherence to bioproduction vessels. In a new 5-minute video, Dr. Elhofy and Essential Pharmaceuticals CEO Allan Weber discuss what makes Cell-Ess so unique and how it's revolutionizing media optimization.
"The data published in this journal, as well as additional studies performed by other groups, demonstrate that Cell-Ess consistently increases protein productivity regardless of the media and feed scheme utilized," says Dr. Elhofy. "The increase in protein productivity has not been shown to impact cell metabolism or glycosylation."
"In order for a study to be published in a peer-reviewed journal, its experimental design and result interpretation must meet rigorous standards," says Allan Weber. "The acceptance of Dr. Elhofy's study for publication confirms the findings of multiple independent groups that Cell-Ess reproducibly boosts protein productivity in a variety of cell culture conditions. Cell-Ess is a game changer for those that aim to improve the efficiency of biotherapeutic development and manufacture."
About Essential Pharmaceuticals
Essential Pharmaceuticals provides transplant surgeons, medical researchers, and manufacturers new tools to bring performance, convenience, and control to enhance the advancement of basic research and drug discovery. Established in 2006, Essential Pharmaceuticals supports the preservation and growth of human systems through expanding its product development to further medical treatments for mankind.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/essential-pharmaceuticals-cso-dr-adam-elhofy-publishes-new-data-on-cell-ess-universal-titer-boost-and-enhancer-300317758.html
SOURCE Essential Pharmaceuticals, LLC